Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record
02:20pm, Saturday, 18'th Feb 2023 MarketWatch
John Buckingham of The Prudent Speculator offers stock picks for investors who share his "passion for value investing."
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
01:14pm, Saturday, 18'th Feb 2023 The Motley Fool
These pharmaceutical stocks probably won't stay so attractively valued for too much longer.
3 Dirt-Cheap Stocks to Buy Sooner Rather Than Later
08:14am, Saturday, 18'th Feb 2023
These pharmaceutical stocks probably won't stay so attractively valued for too much longer.
9 February Inflation-Busting Ideal Dividend Dogs
07:15pm, Friday, 17'th Feb 2023
March-April, 2022, UBS, Kiplinger, and Barron's analysts and reporters combined to list five sets of stocks sorted as: “Inflation Busters.” Those five articles revealed 48 equities, with 43 paying
Pfizer, Alphabet And This ETF: CNBC's 'Final Trades'
01:34pm, Friday, 17'th Feb 2023 Benzinga
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management said Pfizer Inc. (NYSE: PFE) has a 3.8% yield and is trading at 12 times earnings.
Joshua Brown of Ri
Pharma Stock Roundup: FDA Nod to PFE Cibinqo for Adolescents, Updates From NVO, RHHBY
01:33pm, Friday, 17'th Feb 2023 Zacks Investment Research
FDA approves Pfizer's (PFE) Cibinqo for adolescent patients. Roche (RHHBY) announces new positive data from phase III studies on Vabysmo for vision loss associated with retinal vein occlusion.
Moderna’s COVID vaccine will remain free for all Americans in coup for Bernie Sanders
01:24pm, Friday, 17'th Feb 2023 MarketWatch
Moderna Inc. will keep its COVID-19 vaccine available and free of charge for all people in the U.S. even after the public-health emergency ends.
Final Trades: Alphabet, Pfizer & more
02:31pm, Thursday, 16'th Feb 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Pfizer Inc. (PFE) Presents at SVB Securities Global Biopharma Conference (Transcript)
12:49pm, Thursday, 16'th Feb 2023
Pfizer Inc. (NYSE:PFE ) SVB Securities Global Biopharma Conference February 16, 2023 10:00 AM ET Company Participants Andy Schmeltz - Senior Vice President-Commercial Strategy & Innovation Navin Katya
After IPO, Bausch + Lomb turns to an industry favorite to run the company
12:26pm, Thursday, 16'th Feb 2023 MarketWatch
The company's stock was up about 9% in trading on Thursday after the company made the announcement that Brent Saunders will return to Bausch + Lomb as CEO.
New Migraine Drug Offers Sufferers Hope Of ‘Fast-Acting Relief' Via Nasal Spray, Pfizer Says
11:22am, Thursday, 16'th Feb 2023
The FDA is expected to finish its review of the drug by the end of March.
Eli Lilly recruits Black patients for Alzheimer trial as drugmakers seek more diversity in clinical studies
11:02am, Thursday, 16'th Feb 2023
Retailers CVS Health, Walgreens and Kroger have announced new initiatives to provide clinical trial enrollment and follow-up services in their pharmacy clinics.
Competition Coming For AbbVie's Blockbuster Humira
01:08am, Thursday, 16'th Feb 2023
It's among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper “biosimilar” copycats. Relief is on the way for patients who need Humira, a product made by AbbVie.
Is Pfizer Stock A Buy Or A Sell After Pharma Giant Confirms Covid Downfall?
11:28am, Wednesday, 15'th Feb 2023
Is Pfizer stock a buy or a sell after the company guided to massive declines for its Covid products? Is PFE stock a buy or a sell?
Is Moderna Stock A Buy As It Faces Off With Pfizer, GSK In The Massive RSV Market?
11:21am, Wednesday, 15'th Feb 2023
Is Moderna stock a buy after unveiling promising results for its Pfizer- and GSK-rivaling RSV vaccine? Is MRNA stock a buy now?
